Stryker Corp Statement in Response to the Indictment of Its Biotech Division
- The Company is disappointed with this action and still hopes to be able to reach a fair and just resolution of this matter. Conviction of these charges could result in significant monetary fines and Stryker Biotech''s exclusion from participating in federal and state health care programs, which could have a material affect on Stryker Biotech''s business. As a matter of Company policy Stryker will not have any further comment on these allegations.